1,393
Views
4
CrossRef citations to date
0
Altmetric
Special Feature: Stem cell research: current uses and future challenges

Potential of regenerative medicine techniques in canine hepatology

, &
Pages 207-216 | Received 31 Oct 2013, Accepted 10 Dec 2013, Published online: 14 Jan 2014

References

  • Ananthanarayanan A, Narmada BC, Mo X, McMillian M, Yu H. 2011. Purpose-driven biomaterials research in liver-tissue engineering. Trends Biotechnol. 29:110–118.
  • Arends B, Spee B, Schotanus BA, Roskams T, van den Ingh TS, Penning LC, Rothuizen J. 2009a. In vitro differentiation of liver progenitor cells derived from healthy dog livers. Stem Cells Dev. 18:351–358.
  • Arends B, Vankelecom H, Vander Borght S, Roskams T, Penning LC, Rothuizen J, Spee B. 2009b. The dog liver contains a ‘side population’ of cells with hepatic progenitor-like characteristics. Stem Cells Dev. 18:343–350.
  • Baertschiger RM, Serre-Beinier V, Morel P, Bosco D, Peyrou M, Clément S, Sgroi A, Kaelin A, Buhler LH, Gonelle-Gispert C. 2009. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One. 17:e6657. doi:10.1371/journal.pone.0006657
  • Berent AC, Tobias KM. 2009. Portosystemic vascular anomalies. Vet Clin North Am Small Anim Pract. 39:513–541.
  • Boisclair J, Doré M, Beauchamp G, Chouinard L, Girard C. 2001. Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet Pathol. 38:628–635.
  • Bonis PA, Friedman SL, Kaplan MM. 2001. Is liver fibrosis reversible? N England J Med. 344:452–454.
  • Boomkens SY, Penning LC, Egberink HF, van den Ingh TS, Rothuizen J. 2004. Hepatitis with special reference to dogs: a review on the pathogenesis and infectious etiologies, including unpublished results of recent own studies. Vet Q. 26:107–114.
  • Boomkens SY, Slump E, Egberink HF, Rothuizen J, Penning LC. 2005. PCR screening for candidate etiological agents of canine hepatitis. Vet Microbiol. 108:49–55.
  • Boulter L, Lu WY, Forbes SJ. 2013. Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest. 123:1867–1873.
  • Center SA. 2009. Diseases of the gallbladder and biliary tree. Vet Clin North Am Small Anim Pract. 39:543–598.
  • Chio SA, Choi HS, Kim KJ, Lee DS, Lee JH, Park JY, Kim EY, Li X, Oh HY, Lee DS, Kim MK. 2013. Isolation of canine mesenchymal stem cells from amniontic fluid and differentiation into hepatocyte-like cells. In Vitro Cell Dev Biol Anim. 49:42–51.
  • Dorrell C, Erker L, Schug J, Kopp JL, Canaday PS, Fox AJ, Smirnova O, Duncan AW, Finegold MJ, Sander M, et al. 2011. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev. 25:1193–1203.
  • Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. 115:56–65.
  • Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T. 2006. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma: a possible progenitor cell origin. Histopathology. 49:138–151.
  • Fainboim L, Chernavsky A, Paladino N, Flores AC, Arruvito L. 2007. Cytokines and chronic liver disease. Cytokine Growth Factor Rev. 18:143–157.
  • Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB, Theise ND. 2003. Regeneration of hepatocyte ‘buds’ in cirrhosis from intrabiliary stem cells. J Hepatol. 39:357–364.
  • Fausto N. 2004. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 39:1477–1487.
  • Favier RP. 2009. Idiopathic hepatitis and cirrhosis in dogs. Vet Clin North Am Small Anim Pract. 39:481–488.
  • Filioli Uranio M, Valentini L, Lange-Consiglio A, Caira M, Guaricci AC, L’Abbate A, Catacchio CR, Venture M, Cremonesi F, Dell’Aquila ME. 2011. Isolation, proliferation, cytogenetic, and molecular characterization and in vitro differentiation potency of canine stem cells from foetal adnexa: a comparative study of amniontic fluid, amnion, and umbilical cord matrix. Mol Reprod Dev. 78:361–373.
  • Fraczek J, Bolleyn J, Vanhaecke T, Rogiers V, Vinken M. 2013. Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Arch Toxicol. 87:577–610.
  • Friedman SL. 2007. Reversibility of hepatic fibrosis and cirrhosis–is it all hype? Nat Clin Pract Gastroenterol Hepatol. 4:236–237.
  • Friedman SL. 2008. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 88:125–172.
  • Geerts A. 2001. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 21:311–335.
  • Govaere O, Komuta M, Berkers J, Spee B, Janssen C, de Luca F, Katoonizadeh A, Wouters J, van Kempen LC, Durnez A, et al. 2013. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. doi:10.1136/gutjnl-2012-304351
  • Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. 2002. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 7:d793–d807.
  • Grisham JW. 2009. Organizational principles of the liver. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Fausto N, Chafritz DA, Wolkoff AW, The liver biology and pathobiology. 5th ed. Chichester: Wiley-Blackwell; p. 3–15.
  • Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A. 2006. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol. 38:135–151.
  • Hacker HJ, Steinberg P, Toshkov I, Oesch F, Bannasch P. 1992. Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis. 13:271–276.
  • Haraguchi T, Tani K, Takagishi R, Oda Y, Itamoto K, Yamamoto N, Terai S, Sakaida I, Nakazawa H, Taura Y. 2012. Therapeutic potential of canine bone marrow stromal cells (BMSCs) in the carbon tetrachloride (CCl4) induced chronic liver dysfunction mouse model. J Vet Med Sci. 74:607–611.
  • Harding J, Roberts RM, Mirochnitchenko O. 2013. Large animal models for stem cell therapy. Stem Cell Res Ther. 4:23. doi:10.1186/scrt171
  • Hollman DA, Milona A, van Erpecum KJ, van Mil SW. 2012. Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms. Biochim Biophys Acta. 1821:1443–1452.
  • Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, Sato T, Hamer K, Sasaki N, Finegold MJ, et al. 2013. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature. 494:247–250.
  • Ide M, Yamate J, Kuwamura M, Kotani T, Sakuma S, Takeya M. 2001. Immunohistochemical analysis of macrophages and myofibroblasts appearing in hepatic and renal fibrosis of dogs. J Comp Pathol. 124:60–69.
  • IJzer J, Roskams T, Molenbeek RF, Ultee T, Penning LC, Rothuizen J, van den Ingh TS. 2006. Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp Hepatol. 5:7. Available from: http://www.biomedcentral.com/content/pdf/1476-5926-5-7.pdf
  • IJzer J, Schotanus BA, Vander Borght S, Roskams TA, Kisjes R, Penning LC, Rothuizen J, van den Ingh TS. 2010. Characterisation of the hepatic progenitor cell compartment in normal liver and in hepatitis: an immunohistochemical comparison between dog and man. Vet J. 184:308–314.
  • Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, et al. 2005. TWEAK induces liver progenitor cell proliferation. J Clin Invest. 115:2330–2340.
  • Jorns C, Ellis EC, Nowak G, Fischler B, Nemeth A, Strom SC, Ericzon BG. 2012. Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med. 272:201–223.
  • Kapoor A, Simmonds P, Gerold G, Qaisar N, Jain K, Henriquez JA, Firth C, Hirschberg DL, Rice CM, Shields S, Lipkin WI. 2011. Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci USA. 108:11608–11613.
  • Keramaris NC, Kaptanis S, Moss HL, Loppini M, Pneumaticos S, Maffulli N. 2012. Endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) in bone healing. Curr Stem Cell Res Ther. 7:293–301.
  • Kinosita R. 1937. Studies on the cancerogenic chemical substances. Trans Soc Pathol Jpn. 17:665–727.
  • Kiss A, Schnur J, Szabo Z, Nagy P. 2001. Immunohistochemical analysis of atypical ductular reaction in the human liver, with special emphasis on the presence of growth factors and their receptors. Liver. 21:237–246.
  • Knight B, Yeoh GC, Husk KL, Ly T, Abraham LJ, Yu C, Rhim JA, Fausto N. 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med. 192:1809–1818.
  • Koh S, Thomas R, Tsai S, Bischoff S, Lim JH, Breen M, Olby NJ, Piedrahita JA. 2013. Growth requirements and chromosomal instability of induced pluripotent stem cells generated from adult canine fibroblasts. Stem Cells Dev. 22:951–963.
  • Komuta M, Spee B, Vander Borght S, De Vos R, Verslype C, Aerts R, Yano H, Suzuki T, Matsuda M, Fujii H, et al. 2008. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 47:1544–1556.
  • Krause P, Wolff HA, Rave-Frank M, Schmidberger H, Becker H, Hess CF, Christiansen H, Koenig S. 2011. Fractionated external beam radiotherapy as a suitable preparative regimen for hepatocyte transplantation after partial hepatectomy. Int J Radiat Oncol Biol Phys. 80:1214–1219.
  • Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikalyan A, Roberts LR, Demetris AJ, Sun Z, et al. 2006. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 12:410–416.
  • Lemaigre F, Zaret KS. 2004. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev. 4:582–590.
  • Lemaigre FP. 2009. Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 137:62–79.
  • Leveille CR, Arias IM. 1993. Pathophysiology and pharmacologic modulation of hepatic fibrosis. J Vet Intern Med. 7:73–84.
  • Libbrecht L, Roskams T. 2002. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 13:389–396.
  • Luo J, Suhr ST, Chang EA, Wang K, Ross PJ, Nelson LL, Venta PJ, Knott JG, Cibelli JB. 2011. Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem Cells Dev. 20:1669–1678.
  • Meier RP, Müller YD, Morel P, Gonelle-Gispert C, Bühler LH. 2013. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res. 11:1348–1364.
  • Michalopoulos GK. 2007. Liver regeneration. J Cell Physiol. 213:286–300.
  • Mortensen KE, Revhaug A. 2011. Liver regeneration in surgical animal models - a historical perspective and clinical implications. Eur Surg Res. 46:1–18.
  • Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969.
  • Nahmias Y, Kramvis Y, Barbe L, Casali M, Berthiaume F, Yarmush ML. 2006. A novel formulation of oxygen-carrying matrix enhances liver-specific function of cultured hepatocytes. FASEB J. 20:2531–2533.
  • Overturf K, Al-Dhalimy M, Finegold M, Grompe M. 1999. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion. Am J Pathol. 155:2135–2143.
  • Overturf K, Al-Dhalimy M, Ou CN, Finegold M, Grompe M. 1997. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol. 151:1273–1280.
  • Palakkan AA, Hay DC, Anil Kumar PR, Kumary TV, Ross JA. 2013. Liver tissue engineering and cell sources: issues and challenges. Liver Int. 33:666–676.
  • Pan Q, Fouraschen SM, Kaya FS, Verstegen MM, Pescatori M, Stubbs AP, van Ijcken W, van der Sloot A, Smits R, Kwekkeboom J, et al. 2011. Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transplant. 17:596–609.
  • Park SB, Seo MS, Kim JS, Kang KS. 2012. Isolation and characterization of canine amniontic membrane-derived multipotent stem cell. PLoS One. 7:e44693. doi:10.1371/journal.pone.0044693
  • Pascher A, Sauer IM, Walter M, Lopez-Haeninnen E, Theruvath T, Spinelli A, Neuhaus R, Settmacher U, Mueller AR, Steinmueller T, Neuhaus P. 2002. Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transplant. 8:829–837.
  • Poldervaart JH, Favier RP, Penning LC, van den Ingh TS, Rothuizen J. 2009. Primary hepatitis in dogs: a retrospective review (2002-2006). J Vet Intern Med. 23:72–80.
  • Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT, et al. 2012. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. 109:E3186–E3195.
  • Riehle KJ, Dan YY, Campbell JS, Fausto N. 2011. New concepts in liver regeneration. J Gastroenterol Hepatol. 26:203–212.
  • Russell WE, Coffey RJ, Ouellette AJ, Moses HL. 1988. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 85:5126–5130.
  • Schotanus BA, van den Ingh TS, Penning LC, Rothuizen J, Roskams TA, Spee B. 2009. Cross-species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease. Liver Int. 29:1241–1252.
  • Sell S. 2001. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 33:738–750.
  • Seo MS, Jeong YH, Park JR, Park SB, Rho KH, Kim HS, Yu KR, Lee SH, Jung JW, Kang KS. 2009. Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci. 10:181–187.
  • Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, et al. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature. 431:1112–1117.
  • Si-Tayeb K, Lemaigre FP, Duncan SA. 2010. Organogenesis and development of the liver. Dev Cell. 18:175–189.
  • Smedsrod B, De Bleser PJ, Braet F, Lovisetti P, Vanderkerken K, Wisse E, Geerts A. 1994. Cell biology of liver endothelial and Kupffer cells. Gut. 35:1509–1516.
  • Spee B, Arends B, van den Ingh TS, Brinkhof B, Nederbragt H, IJzer J, Roskams T, Penning LC, Rothuizen J. 2006. Transforming growth factor beta-1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies. Liver Int. 26:716–725.
  • Spee B, Arends B, van den Ingh TS, Roskams T, Rothuizen J, Penning LC. 2007. Major HGF-mediated regenerative pathways are similarly affected in human and canine cirrhosis. Comp Hepatol. 6:8. doi:10.1186/1476-5926-6-8
  • Spee B, Penning LC, van den Ingh TS, Arends B, IJzer J, van Sluijs FJ, Rothuizen J. 2005. Regenerative and fibrotic pathways in canine hepatic portosystemic shunt and portal vein hypoplasia, new models for clinical hepatocyte growth factor treatment. Comp Hepatol. 4:7. doi:10.1186/1476-5926-4-7
  • Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126:663–676.
  • Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, et al. 2013. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 499:481–484.
  • Taub R. 2004. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 5:836–847.
  • Tietz PS, Larusso NF. 2006. Cholangiocyte biology. Curr Opin Gastroenterol. 22:279–287.
  • Tirnitz-Parker JE, Olynyk JK, Ramm GA. 2013. Role of TWEAK in co-regulating liver progenitor cell and fibrogenic responses. Hepatology. doi:10.1002/hep.26701
  • van den Ingh TSGAM, Van Winkle T, Cullen JM, Charles JA, Desmet VJ. 2006. Morphological classification of parenchymal disorders of the canine and feline liver: 2. Hepatocellular death, hepatitis and cirrhosis. In: Rothuizen J, Bunch SE, Charles JA, Cullen JM, Desmet VJ, Szatmar V, Twedt DC, van den Ingh TSGAM, Van Winkle T, Washabau RJ, editors. WSAVA standards for clinical and histological diagnosis of canine and feline liver disease. Edinburgh: Saunders-Elsevier; p. 85–102.
  • van der Heijden M, de Vries M, van Steenbeek FG, Facier RP, Deijs M, Brinkhof B, Rothuizen J, van der Hoek L, Penning LC. 2012. Sequence-independent VIDISCA-454 technique to discover new viruses in canine livers. J Virol Methods. 185:152–155.
  • van Sprundel RG, van den Ingh TS, Guscetti F, Kershaw O, Kanemoto H, van Gils HM, Rothuizen J, Roskams T, Spee B. 2013. Classification of primary hepatic tumours in the dog. Vet J. 197:596–606.
  • Watson PJ. 2004. Chronic hepatitis in dogs: a review of current understanding of the aetiology, progression, and treatment. Vet J. 167:228–241.
  • Watson PJ, Roulois AJ, Scase TJ, Irvine R, Herrtage ME. 2010. Prevalence of hepatic lesions at post-mortem examination in dogs and association with pancreatitis. J Small Anim Pract. 51:566–572.
  • Wenceslau CV, Miglino MA, Martins DS, Ambrósio CE, Lizier NF, Pignatari GC, Kerkis I. 2011. Mesenchymal progenitor cells from canine fetal tissues: yolk sac, liver, and bone marrow. Tissue Eng Part A. 17:2165–2176.
  • Whitworth DJ, Ovchinnikov DA, Wolvetang E. 2012. Generation and characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev. 21:2288–2297.
  • Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. 2007. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity. 26:117–129.
  • Yoshioka K, Enaga S, Taniguchi K, Fukushima U, Uechi M, Mutoh K. 2004. Morphological characterization of ductular reactions in canine liver disease. J Comp Pathol. 130:92–98.
  • Zhao R, Duncan SA. 2005. Embryonic development of the liver. Hepatology. 41:956–967.
  • Zhou H, Dong X, Kabarriti R, Chen Y, Avsar Y, Wang X, Ding J, Liu L, Fox IJ, Roy-Chowdhury J, et al. 2012. Single liver lobe repopulation with wildtype hepatocytes using regional hepatic irradiation cures jaundice in Gunn rats. PLoS One. 7:e46775. doi:10.1371/journal.pone.0046775
  • Zucconi E, Vieira NM, Bueno DF, Secco M, Jazedie T, Ambrosio CE, Passos-Bueno MR, Miglino MA, Zatz M. 2010. Mesenchymal stem cells derived from canine umbilical cord vein – a novel source for cell therapy studies. Stem Cells Dev. 19:395–402.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.